Publishers have led themselves into a mess by focusing on rising submissions as a positive indicator of journal performance. The time has come to close the floodgates and require that authors demonstrate their commitment to quality science before we let them in the door.
Analysis from Roger Schonfeld on today’s news that Silverchair is buying ScholarOne from Clarivate, a transaction that realigns infrastructure and allows each to focus on its strengths.
“Researchers have only so many hours in a day; if they can spend one less hour on a research article because we have implemented improved workflows and better technology, that’s one more hour they can spend on research to try to save my life, and the lives of all ALS patients.” In today’s post, Bruce Rosenblum shares his experience as a clinical trial participant and how that contributed to scholarly publications.